Modulatory Effects of NBF1, an Algal Fiber-Rich Bioformula, on Adiponectin and C-Reactive Protein Levels, and Its Therapeutic Prospects for Metabolic Syndrome and Type-2 Diabetes Patients

被引:3
|
作者
Ngatu, Nlandu Roger [1 ]
Ikeda, Mitsunori [2 ]
Tonduangu, Daniel Kuezina [3 ]
Nangana, Severin Luzitu [4 ]
Hirao, Tomohiro [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa 7610793, Japan
[2] Univ Kochi, Wellness & Longev Ctr, Kochi 7818515, Japan
[3] Univ Kinshasa, Fac Med, Dept Internal Med, Kinshasa, DEM REP CONGO
[4] Kimbanguist Hosp Kinshasa, Prevent Med Unit, Kinshasa, DEM REP CONGO
关键词
adiponectin; C-reactive protein; metabolic marker; sujiaonori; SULFATED POLYSACCHARIDES; BIOLOGICAL-ACTIVITIES; INSULIN-RESISTANCE; DISEASE; DIET; RISK; ASSOCIATION; PREDICTOR; BENEFITS;
D O I
10.3390/biomedicines10102572
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An unhealthy diet can lead to the development of metabolic disorders. C-reactive protein (CRP) has been reported to be an inflammatory component of metabolic disorders. Additionally, reduced adiponectin (APN) levels is known as a predictor of metabolic disorders. We report on the beneficial effects of NBF1, an algal fiber-rich formula, on CRP, APN, and diabetes markers. Additionally, associations between dietary nutrients, CRP, and APN were investigated. A dietary survey that used a brief self-administered diet history questionnaire, a validated 58-item fixed-portion-type questionnaire, and a 4-week placebo-controlled dietary intervention were carried out. The latter consisted of a twice daily intake of 3 g of sujiaonori alga-based powder as a supplement (NBF1, n = 16), whereas the placebo group received the same amount of corn starch powder (n = 15). CRP and APN levels were assayed by ELISA. Clinical cases comprising three subjects with metabolic disorders treated with NBF1, including two type 2 diabetes mellitus patients and one subject with hypercholesterolemia, are also reported. They received 2.1g NBF1 once daily for 12 weeks. Intakes of algal fiber and n-3 PUFA were positively associated with the increase of APN, and n-3PUFA intake was inversely associated with CRP. All cases had improved metabolic health profile.
引用
收藏
页数:10
相关论文
共 24 条
  • [1] C-REACTIVE PROTEIN IN OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
    del Canizo-Gomez, F. J.
    Moreira-Andres, M. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 117 - 117
  • [2] Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes
    Kahn, Steven E.
    Zinman, Bernard
    Haffner, Steven M.
    O'Neill, M. Colleen
    Kravitz, Barbara G.
    Yu, Dahong
    Freed, Martin I.
    Herman, William H.
    Holman, Rury R.
    Jones, Nigel P.
    Lachin, John M.
    Viberti, Giancarlo C.
    DIABETES, 2006, 55 (08) : 2357 - 2364
  • [3] Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
    Niafar, Mitra
    Pourafkari, Leili
    Shahsavarinia, Kavus
    Milanchian, Nushin
    Niafar, Farhad
    Nader, Nader D.
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2016, 8 (01) : 8 - 12
  • [4] Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction Of type 2 diabetes
    Brantsma, AH
    Bakker, SJL
    Hillege, HL
    De Zeeuw, D
    De Jong, PE
    Gansevoort, RT
    DIABETES CARE, 2005, 28 (10) : 2525 - 2530
  • [5] High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome
    Rosolova, Hana
    Petrlova, Barbora
    Simon, Jaroslav
    Sifalda, Pavel
    Sipova, Iva
    MEDICAL SCIENCE MONITOR, 2008, 14 (08): : CR411 - CR415
  • [6] Obesity is a major determinant ofthe association of C-reactive protein levels with the number of metabolic syndrome components in type 2 diabetes
    Kahn, SE
    Zinman, B
    Viberti, G
    Kravitz, BG
    Yu, DH
    Heise, MA
    Freed, MI
    DIABETES, 2005, 54 : A255 - A255
  • [7] Effects of rosiglitazone treatment on levels of C-reactive protein and MMP9 in patients with Type 2 diabetes
    Haffner, SM
    Greenberg, A
    Weston, W
    Fuell, D
    Chen, HZ
    Freed, M
    CIRCULATION, 2001, 104 (17) : 117 - 118
  • [8] Serum high-sensitivity C-reactive protein levels in comorbid patients with type-2 diabetes mellitus and periodontal disease
    Tan Jiawei
    Pan Lulu
    Xu Guochao
    Xiang Lixin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (09) : 1881 - 1884
  • [9] C-reactive protein as an inflammatory marker in obese and non-obese type 2 diabetes mellitus patients with metabolic syndrome
    Siddiqui, Rabia
    Rukhsana, Nighat
    Jafri, Muhammad Sajid Abbas
    Shakoor, Shazia
    Iqbal, Samreen
    Younas, Muhammad
    RAWAL MEDICAL JOURNAL, 2024, 49 (04):
  • [10] The relationship of management modality in Saudi patients with type 2 diabetes to components of metabolic syndrome, γ glutamyl transferase and highly sensitive C-reactive protein
    Bahijri, Suhad M.
    Ahmed, Maimoona
    Al-Shali, Khalid
    Bokhari, Samia
    Alhozali, Amani
    Borai, Anwar
    Gusti, Amani
    Ajabnoor, Ghada
    Alghamdi, Ahmed
    Asiri, Mohammed
    Tuomilehto, Jaakko
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (05) : 246 - 254